FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145060571> ?p ?o ?g. }

• W2145060571 endingPage "360" @default.
• W2145060571 startingPage "353" @default.
• W2145060571 abstract "Infantile Pompe disease progresses to a lethal cardiomyopathy in absence of effective treatment. Enzyme-replacement therapy (ERT) with recombinant human acid alpha-glucosidase (rhGAA) has been effective in most patients with Pompe disease, but efficacy was reduced by high-titer antibody responses. Immunomodulatory gene therapy with a low dose adeno-associated virus (AAV) vector (2 x 10(10) particles) containing a liver-specific regulatory cassette significantly lowered immunoglobin G (IgG), IgG1, and IgE antibodies to GAA in Pompe disease mice, when compared with mock-treated mice (P < 0.05). AAV-LSPhGAApA had the same effect on GAA-antibody production whether it was given prior to, following, or simultaneously with the initial GAA injection. Mice given AAV-LSPhGAApA had significantly less decrease in body temperature (P < 0.001) and lower anaphylactic scores (P < 0.01) following the GAA challenge. Mouse mast cell protease-1 (MMCP-1) followed the pattern associated with hypersensitivity reactions (P < 0.05). Regulatory T cells (Treg) were demonstrated to play a role in the tolerance induced by gene therapy as depletion of Treg led to an increase in GAA-specific IgG (P < 0.001). Treg depleted mice were challenged with GAA and had significantly stronger allergic reactions than mice given gene therapy without subsequent Treg depletion (temperature: P < 0.01; symptoms: P < 0.05). Ubiquitous GAA expression failed to prevent antibody formation. Thus, immunomodulatory gene therapy could provide adjunctive therapy in lysosomal storage disorders treated by enzyme replacement." @default.
• W2145060571 created "2016-06-24" @default.
• W2145060571 creator A5006645827 @default.
• W2145060571 creator A5008425789 @default.
• W2145060571 creator A5028156079 @default.
• W2145060571 creator A5037775852 @default.
• W2145060571 creator A5045134210 @default.
• W2145060571 creator A5045419573 @default.
• W2145060571 creator A5055884753 @default.
• W2145060571 creator A5059471646 @default.
• W2145060571 creator A5062901617 @default.
• W2145060571 creator A5064225996 @default.
• W2145060571 creator A5087230640 @default.
• W2145060571 creator A5090945180 @default.
• W2145060571 date "2010-02-01" @default.
• W2145060571 modified "2023-10-16" @default.
• W2145060571 title "Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease" @default.
• W2145060571 cites W1599413902 @default.
• W2145060571 cites W1965222084 @default.
• W2145060571 cites W1969555423 @default.
• W2145060571 cites W1975725635 @default.
• W2145060571 cites W1978223939 @default.
• W2145060571 cites W1983318494 @default.
• W2145060571 cites W1985656844 @default.
• W2145060571 cites W1986484885 @default.
• W2145060571 cites W1998848589 @default.
• W2145060571 cites W2011292209 @default.
• W2145060571 cites W2012445121 @default.
• W2145060571 cites W2022356406 @default.
• W2145060571 cites W2030487155 @default.
• W2145060571 cites W2034625094 @default.
• W2145060571 cites W2036877355 @default.
• W2145060571 cites W2043739107 @default.
• W2145060571 cites W2045817726 @default.
• W2145060571 cites W2047608515 @default.
• W2145060571 cites W2050193680 @default.
• W2145060571 cites W2054318592 @default.
• W2145060571 cites W2055655054 @default.
• W2145060571 cites W2065452485 @default.
• W2145060571 cites W2068756091 @default.
• W2145060571 cites W2073739917 @default.
• W2145060571 cites W2076454500 @default.
• W2145060571 cites W2076860206 @default.
• W2145060571 cites W2084276666 @default.
• W2145060571 cites W2085884984 @default.
• W2145060571 cites W2090607175 @default.
• W2145060571 cites W2099289539 @default.
• W2145060571 cites W2109581185 @default.
• W2145060571 cites W2127608615 @default.
• W2145060571 cites W2130528924 @default.
• W2145060571 cites W2149699328 @default.
• W2145060571 cites W2158749858 @default.
• W2145060571 cites W2168251691 @default.
• W2145060571 cites W2313827278 @default.
• W2145060571 cites W4211164442 @default.
• W2145060571 doi "https://doi.org/10.1038/mt.2009.195" @default.
• W2145060571 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2818301" @default.
• W2145060571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19690517" @default.
• W2145060571 hasPublicationYear "2010" @default.
• W2145060571 type Work @default.
• W2145060571 sameAs 2145060571 @default.
• W2145060571 citedByCount "76" @default.
• W2145060571 countsByYear W21450605712012 @default.
• W2145060571 countsByYear W21450605712013 @default.
• W2145060571 countsByYear W21450605712014 @default.
• W2145060571 countsByYear W21450605712015 @default.
• W2145060571 countsByYear W21450605712016 @default.
• W2145060571 countsByYear W21450605712017 @default.
• W2145060571 countsByYear W21450605712018 @default.
• W2145060571 countsByYear W21450605712019 @default.
• W2145060571 countsByYear W21450605712020 @default.
• W2145060571 countsByYear W21450605712021 @default.
• W2145060571 countsByYear W21450605712022 @default.
• W2145060571 countsByYear W21450605712023 @default.
• W2145060571 crossrefType "journal-article" @default.
• W2145060571 hasAuthorship W2145060571A5006645827 @default.
• W2145060571 hasAuthorship W2145060571A5008425789 @default.
• W2145060571 hasAuthorship W2145060571A5028156079 @default.
• W2145060571 hasAuthorship W2145060571A5037775852 @default.
• W2145060571 hasAuthorship W2145060571A5045134210 @default.
• W2145060571 hasAuthorship W2145060571A5045419573 @default.
• W2145060571 hasAuthorship W2145060571A5055884753 @default.
• W2145060571 hasAuthorship W2145060571A5059471646 @default.
• W2145060571 hasAuthorship W2145060571A5062901617 @default.
• W2145060571 hasAuthorship W2145060571A5064225996 @default.
• W2145060571 hasAuthorship W2145060571A5087230640 @default.
• W2145060571 hasAuthorship W2145060571A5090945180 @default.
• W2145060571 hasBestOaLocation W21450605711 @default.
• W2145060571 hasConcept C104317684 @default.
• W2145060571 hasConcept C111599444 @default.
• W2145060571 hasConcept C126322002 @default.
• W2145060571 hasConcept C141105273 @default.
• W2145060571 hasConcept C159654299 @default.
• W2145060571 hasConcept C181199279 @default.
• W2145060571 hasConcept C203014093 @default.
• W2145060571 hasConcept C2776735236 @default.
• W2145060571 hasConcept C2779134260 @default.
• W2145060571 hasConcept C2779969927 @default.

• next